advertisement
11.8 Neuroprotection (315)
Showing records 1 to 25
Display all abstracts in classification 11.8 Neuroprotection
Search within classification 11.8 Neuroprotection60245 Discovery of novel inhibitors for the treatment of glaucoma
Cholkar K
Expert Opinion on Drug Discovery 2015; 10: 293-313
60802 Analysis of the Expression and Polymorphism of APOE, HSP, BDNF, and GRIN2B Genes Associated with the Neurodegeneration Process in the Pathogenesis of Primary Open Angle Glaucoma
Nowak A
BioMed research international 2015; 2015: 258281
60639 Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol
Lindsey JD
Neurobiology of Aging 2015; 0:
60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Garway-Heath DF
Lancet 2015; 385: 1295-1304
60355 Role of CtBP2 in the Apoptosis of Retinal Ganglion Cells
Wang W
Cellular and molecular neurobiology 2015; 35: 633-640
60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Chen YS
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193
60683 P2X7 receptor antagonists protect against N-methyl-d-aspartic acid-induced neuronal injury in the rat retina
Sakamoto K
European Journal of Pharmacology 2015; 756: 52-58
60430 Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve
Coughlin L
Investigative Ophthalmology and Visual Science 2015; 56: 1437-1446
60362 MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD)
Parsons CG
Neuropharmacology 2015; 92: 158-169
60791 Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
Stein JD
PLoS ONE 2015; 10: e0123682
60620 Neurodegeneration severity is anticipated by early microglia alterations monitored in vivo in a mouse model of chronic glaucoma
Bosco A
Disease models & mechanisms 2015; 0:
60689 Protective effect of molecular hydrogen against oxidative stress caused by peroxynitrite derived from nitric oxide in rat retina
Yokota T
Clinical and Experimental Ophthalmology 2015; 43: 568-577
60328 Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model
Emre E
Cytotherapy 2015; 17: 543-559
60617 An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse
Crowston JG
Experimental Eye Research 2015; 141: 3-8
60213 Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma
Kimura A
Neuroscience Letters 2015; 588: 108-113
60792 c-Jun N-terminal kinase 3 expression in the retina of ocular hypertension mice: a possible target to reduce ganglion cell apoptosis
He Y
Neural Regeneration Research 2015; 10: 432-437
60246 Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors
Ortín-Martínez A
Experimental Eye Research 2015; 132: 17-33
60356 Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model
White AJ
Journal of the renin-angiotensin-aldosterone system : JRAAS 2015; 16: 1193-1201
60217 Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes
Ju WK
GLIA 2015; 63: 736-753
60587 Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis
Guo X
Neuroscience Letters 2015; 592: 27-31
60186 Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling
Kimura A
American Journal of Pathology 2015; 185: 756-764
60085 Glial cell interactions and glaucoma
Chong RS
Current Opinions in Ophthalmology 2015; 26: 73-77
60534 Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress
Sappington RM
Channels (Austin, Tex.) 2015; 9: 102-113
60616 Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy
Parameswaran S
Stem Cells 2015; 33: 1743-1758
60671 Neuroprotective therapies for glaucoma
Song W
Drug design, development and therapy 2015; 9: 1469-1479
